ACAD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ACADIA Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 21.72 USD 1.35% Market Closed

Market Cap: $3.7B

	ACADIA Pharmaceuticals Inc NASDAQ:ACAD	US
	Paymentus Holdings Inc NYSE:PAY	US
	Aptose Biosciences Inc TSX:APS	CA
	Bridgewater Bancshares Inc NASDAQ:BWB	US
	Bureau Veritas SA F:4BV0	FR
P	Pierre et Vacances SA F:PV6	FR
	Nuvista Energy Ltd TSX:NVA	CA
	DHT Holdings Inc NYSE:DHT	BM
A	ALM Equity AB STO:ALM	SE
C	CSP International Fashion Group SpA MIL:CSP	IT
C	Christian Dior SE OTC:CHDRY	FR
T	TotalEnergies SE F:TOTA	FR
N	Nano One Materials Corp SWB:LBMB	CA
E	EBR Systems Inc ASX:EBR	US
	Eupraxia Pharmaceuticals Inc TSX:EPRX	CA

Profitability Summary

ACADIA Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

92%

Strong 3Y Average Gross Margin

97%

Declining Gross Margin

98% > 92%

Low Operating Margin

10%

Strong 3Y Average Operating Margin

33%

Operating Margin is Increasing

-32% > 10%

Exceptional Net Margin

36%

Strong 3Y Average Net Margin

47%

Net Margin is Increasing

-28% > 36%

Healthy Free Cash Flow Margin

Strong 3Y Average Free Cash Flow Margin

19%

Free Cash Flow Margin is Increasing

-28% > 1%

Exceptional ROE

40%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

88%

ROIC is Increasing

-82% > 834%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.